[Skip to Content]
[Skip to Content Landing]
Controversies in Neurology
June 1999

Do We Have Drugs for Dementia?No

Author Affiliations

From Memorial University of Newfoundland, Canada



Arch Neurol. 1999;56(6):735-737. doi:10.1001/archneur.56.6.735

ADDRESSING causative rather than symptomatic treatments, I suggest that the following are the appropriate goals of antidementia therapy: (1) to improve the patient's capacity to perform the basic or instrumental activities of daily living; (2) to improve the quality of life of the patient and/or the caregiver; (3) to improve memory and other cognitive and behavioral functions to the extent that this leads to clinically relevant improvements; and (4) to slow the course of the disease with respect to measurable cognitive decline and the level of care required, in comparison with placebo therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview